These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8809164)

  • 21. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol class.
    Sofia MJ; Floreancig P; Bach N; Baker SR; Nelson K; Sawyer JS; Baldwin R; Cockerham SL; Fleisch JH; Froelich LL; Jackson WT; Marder P; Roman CR; Saussy DL; Silbaugh SA; Spaethe SM; Stengel PW
    Adv Exp Med Biol; 1997; 400A():381-6. PubMed ID: 9547580
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
    Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
    J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Tzimas MN; Martin LD; Daines RA; Chambers PA; Kingsbury WD; Griswold DE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():275-7. PubMed ID: 7732852
    [No Abstract]   [Full Text] [Related]  

  • 26. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
    Bang-Andersen B; Lenz SM; Skjaerbaek N; Søby KK; Hansen HO; Ebert B; Bøgesø KP; Krogsgaard-Larsen P
    J Med Chem; 1997 Aug; 40(18):2831-42. PubMed ID: 9288165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
    Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
    J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.
    Lowe RF; Nelson J; Dang TN; Crowe PD; Pahuja A; McCarthy JR; Grigoriadis DE; Conlon P; Saunders J; Chen C; Szabo T; Chen TK; Bozigian H
    J Med Chem; 2005 Mar; 48(5):1540-9. PubMed ID: 15743196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists.
    Sofia MJ; Floreancig P; Bach NJ; Baker SR; Cockerham SL; Fleisch JH; Froelich LL; Jackson WT; Marder P; Roman CR
    J Med Chem; 1993 Nov; 36(24):3978-81. PubMed ID: 7902871
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
    J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzodiazepine receptor affinity and interaction of new indole derivatives.
    Da Settimo A; Primofiore G; Da Settimo F; Lucacchini A; Martini C; Senatore G
    Farmaco; 1993 Feb; 48(2):285-95. PubMed ID: 8388216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acid.
    Hutchinson JH; Riendeau D; Brideau C; Chan C; Falgueyret JP; Guay J; Jones TR; Lépine C; Macdonald D; McFarlane CS
    J Med Chem; 1994 Apr; 37(8):1153-64. PubMed ID: 8164257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists.
    Sawyer JS; Baldwin RF; Sofia MJ; Floreancig P; Marder P; Saussy DL; Froelich LL; Silbaugh SA; Stengel PW; Cockerham SL
    J Med Chem; 1993 Nov; 36(24):3982-4. PubMed ID: 8254628
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5.
    Rowbottom MW; Tucci FC; Connors PJ; Gross TD; Zhu YF; Guo Z; Moorjani M; Acevedo O; Carter L; Sullivan SK; Xie Q; Fisher A; Struthers RS; Saunders J; Chen C
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4967-73. PubMed ID: 15341961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the characteristics of leukotriene B4 receptor with radio-ligand binding assay].
    Zhao N; Zhu XY; Cheng GF
    Yao Xue Xue Bao; 1996; 31(11):875-7. PubMed ID: 9863260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.